STOCK TITAN
  1. Home
  2. Sec-filings
  3. SNWV
  4. [Form 4] SANUWAVE Health, Inc. Insider Trading Activity

[Form 4] SANUWAVE Health, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Ian D. Miller, a director of SANUWAVE Health, Inc. (SNWV), reported a Form 4 showing the acquisition on 09/30/2025 of 1,510 stock options with an exercise price of $37.48. The options were reported as fully vested at grant and are exercisable beginning 09/30/2025 with an expiration of 09/30/203010/02/2025. The filing lists the reporting person’s address in Eden Prairie, MN and indicates the Form was filed by one reporting person.

Ian D. Miller, un direttore di SANUWAVE Health, Inc. (SNWV), ha riferito un Modulo 4 che mostra l'acquisizione il 30/09/2025 di 1.510 opzioni azionarie con prezzo di esercizio di $37,48. Le opzioni sono state riportate come completamente maturate al momento dell'assegnazione e sono esercitabili a partire dal 30/09/2025 con scadenza al 30/09/2030. Il Modulo 4 è stato firmato da un procuratore il 02/10/2025. La dichiarazione riporta l'indirizzo della persona che segnala a Eden Prairie, MN e indica che il Modulo è stato presentato da una sola persona che segnala.

Ian D. Miller, un director de SANUWAVE Health, Inc. (SNWV), reportó un Formulario 4 que muestra la adquisición el 30/09/2025 de 1,510 opciones de acciones con un precio de ejercicio de $37,48. Las opciones se informaron como totalmente vested al momento de la concesión y son exercibles a partir del 30/09/2025 con una expiración del 30/09/2030. El Formulario 4 fue firmado por un apoderado el 02/10/2025. La presentación lista la dirección de la persona que informa en Eden Prairie, MN y indica que el Formulario fue presentado por una persona informante.

Ian D. Miller는 SANUWAVE Health, Inc. (SNWV)의 이사로서, 09/30/2025에 1,510주 옵션을 행사가격 $37.48으로 취득했다는 Form 4를 보고했다. 옵션은 부여 시점에 완전히 취득으로 보고되었으며, 2025년 9월 30일부터 행사가 가능하고 만료일은 2030년 9월 30일이다. Form 4는 대리인에 의해 2025년 10월 2일에 서명되었다. 보고자의 주소는 에덴프레이리, 미네소타이며 제출은 한 명의 보고자가 제출한 것으로 표시된다.

Ian D. Miller, un directeur de SANUWAVE Health, Inc. (SNWV), a déclaré un Formulaire 4 montrant l'acquisition le 30/09/2025 de 1 510 options d'achat avec un prix d'exercice de $37,48. Les options ont été reportées comme entièrement acquises à la remise et sont exerçables à partir du 30/09/2025 avec une expiration le 30/09/2030. Le Formulaire 4 a été signé par un mandataire le 02/10/2025. Le dépôt indique l'adresse de la personne déclarant à Eden Prairie, MN et indique que le formulaire a été déposé par une personne déclarant.

Ian D. Miller, ein Direktor von SANUWAVE Health, Inc. (SNWV), berichtete von einem Form 4, das den Erwerb am 30.09.2025 von 1.510 Aktienoptionen mit einem Ausübungspreis von $37,48 zeigt. Die Optionen wurden als vollständig vestet bei Gewährung angegeben und können ab dem 30.09.2025 ausgeübt werden und verfallen am 30.09.2030. Das Form 4 wurde von einem Bevollmächtigten am 02.10.2025 unterschrieben. Die Einreichung listet die Adresse der meldenden Person in Eden Prairie, MN und gibt an, dass das Formular von einer meldenden Person eingereicht wurde.

إيان د. ميلر، مدير في SANUWAVE Health, Inc. (SNWV)، أبلغ عن نموذج 4 يظهر الاستحواذ في 30/09/2025 على 1,510 من خيارات الأسهم بسعر ممارسة قدره $37,48. تم الإبلاغ عن الخيارات بأنها مكتملة الحيازة عند المنحة وهي قابلة للممارسة ابتداءً من 30/09/2025 وبانتهاء 30/09/2030. تم توقيع نموذج 4 من قبل وكيل بالنيابة في 02/10/2025. تُدرج الإيداع عنوان الشخص المبلّغ في Eden Prairie, MN وتوضح أن النموذج قد قدمته شخص واحد مبلّغ عنه.

Ian D. Miller，是 SANUWAVE Health, Inc. (SNWV) 的 董事，据报出 Form 4，显示在 2025/09/30 获得 1,510 份股票期权，行使价为 $37,48。这些期权在授予时被报告为 已完全归属，并且自 2025/09/30 起可行使，到期日为 2030/09/30。该 Form 4 由一名代理人于 2025/10/02 签署。备案列出报告人地址在 Eden Prairie, MN，并表示该表格由一名报告人提交。

Positive
  • None.
Negative
  • None.

Ian D. Miller, un direttore di SANUWAVE Health, Inc. (SNWV), ha riferito un Modulo 4 che mostra l'acquisizione il 30/09/2025 di 1.510 opzioni azionarie con prezzo di esercizio di $37,48. Le opzioni sono state riportate come completamente maturate al momento dell'assegnazione e sono esercitabili a partire dal 30/09/2025 con scadenza al 30/09/2030. Il Modulo 4 è stato firmato da un procuratore il 02/10/2025. La dichiarazione riporta l'indirizzo della persona che segnala a Eden Prairie, MN e indica che il Modulo è stato presentato da una sola persona che segnala.

Ian D. Miller, un director de SANUWAVE Health, Inc. (SNWV), reportó un Formulario 4 que muestra la adquisición el 30/09/2025 de 1,510 opciones de acciones con un precio de ejercicio de $37,48. Las opciones se informaron como totalmente vested al momento de la concesión y son exercibles a partir del 30/09/2025 con una expiración del 30/09/2030. El Formulario 4 fue firmado por un apoderado el 02/10/2025. La presentación lista la dirección de la persona que informa en Eden Prairie, MN y indica que el Formulario fue presentado por una persona informante.

Ian D. Miller는 SANUWAVE Health, Inc. (SNWV)의 이사로서, 09/30/2025에 1,510주 옵션을 행사가격 $37.48으로 취득했다는 Form 4를 보고했다. 옵션은 부여 시점에 완전히 취득으로 보고되었으며, 2025년 9월 30일부터 행사가 가능하고 만료일은 2030년 9월 30일이다. Form 4는 대리인에 의해 2025년 10월 2일에 서명되었다. 보고자의 주소는 에덴프레이리, 미네소타이며 제출은 한 명의 보고자가 제출한 것으로 표시된다.

Ian D. Miller, un directeur de SANUWAVE Health, Inc. (SNWV), a déclaré un Formulaire 4 montrant l'acquisition le 30/09/2025 de 1 510 options d'achat avec un prix d'exercice de $37,48. Les options ont été reportées comme entièrement acquises à la remise et sont exerçables à partir du 30/09/2025 avec une expiration le 30/09/2030. Le Formulaire 4 a été signé par un mandataire le 02/10/2025. Le dépôt indique l'adresse de la personne déclarant à Eden Prairie, MN et indique que le formulaire a été déposé par une personne déclarant.

Ian D. Miller, ein Direktor von SANUWAVE Health, Inc. (SNWV), berichtete von einem Form 4, das den Erwerb am 30.09.2025 von 1.510 Aktienoptionen mit einem Ausübungspreis von $37,48 zeigt. Die Optionen wurden als vollständig vestet bei Gewährung angegeben und können ab dem 30.09.2025 ausgeübt werden und verfallen am 30.09.2030. Das Form 4 wurde von einem Bevollmächtigten am 02.10.2025 unterschrieben. Die Einreichung listet die Adresse der meldenden Person in Eden Prairie, MN und gibt an, dass das Formular von einer meldenden Person eingereicht wurde.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Miller Ian D.
(Last) (First) (Middle)
9600 W. 7TH STREET
SUITE 118
(Street)
EDEN PRAIRIE MN 55344
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
SANUWAVE Health, Inc. [ SNVW ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
09/30/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy) $37.48 09/30/2025 A 1,510 (1) 09/30/2030 Common Stock 1,510 $0 1,510 D
Explanation of Responses:
1. Options were fully vested at the grant date.
/s/ Griffin D. Foster, Attorney-in-Fact for Ian D. Miller 10/02/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What transaction did Ian D. Miller report for SANUWAVE (SNWV)?

He reported the acquisition of 1,510 stock options on 09/30/2025 with an exercise price of $37.48.

What is the exercisable and expiration schedule for the options?

The options are exercisable starting 09/30/2025 and expire on 09/30/2030.

Were the options vested at grant according to the filing?

Yes. The filing states: Options were fully vested at the grant date.

Who signed the Form 4 and when was it filed?

The Form 4 was signed by Griffin D. Foster, Attorney-in-Fact, and dated 10/02/2025.

What is the reporting person’s relationship to SANUWAVE?

The filing checks Director as the reporting person’s relationship to the issuer.
Stock SNWV logo
Sanuwave Health

NASDAQ:SNWV

SNWV Rankings

#3837 Ranked by Market Cap
N/A Ranked by Dividends

SNWV Latest News

SNWV Latest SEC Filings

SNWV Stock Data

313.33M
8.09M
5.57%
41.15%
5.59%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
SUWANEE